Cumulatively, these effects, after leptin administration, reduce obesity in mouse models of obesity and in human patients with homozygous Lep mutations or congenital Lep deficiency [17–19]. The gene discussed is LEP; the disease is hyperinsulinemic hypoglycemia, familial, 4.